GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioDelivery Sciences International Inc (NAS:BDSI) » Definitions » Price-to-Tangible-Book

BioDelivery Sciences International (BioDelivery Sciences International) Price-to-Tangible-Book : 4.59 (As of Apr. 26, 2024)


View and export this data going back to 2002. Start your Free Trial

What is BioDelivery Sciences International Price-to-Tangible-Book?

As of today (2024-04-26), BioDelivery Sciences International's share price is $5.59. BioDelivery Sciences International's Tangible Book per Share of Dec. 2021 for the quarter that ended in Dec. 2021 was $1.22. Hence, BioDelivery Sciences International's Price to Tangible Book Ratio of today is 4.59.

The historical rank and industry rank for BioDelivery Sciences International's Price-to-Tangible-Book or its related term are showing as below:

BDSI' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.55   Med: 9   Max: 3550
Current: 4.58

During the past 13 years, BioDelivery Sciences International's highest Price to Tangible Book Ratio was 3550.00. The lowest was 2.55. And the median was 9.00.

BDSI's Price-to-Tangible-Book is not ranked
in the Drug Manufacturers industry.
Industry Median: 2.36 vs BDSI: 4.58

A closely related ratio is called PB Ratio. As of today, BioDelivery Sciences International's share price is $5.59. BioDelivery Sciences International's Book Value per Sharefor the quarter that ended in Dec. 2021 was $1.85. Hence, BioDelivery Sciences International's P/B Ratio of today is 3.02.


BioDelivery Sciences International Price-to-Tangible-Book Historical Data

The historical data trend for BioDelivery Sciences International's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioDelivery Sciences International Price-to-Tangible-Book Chart

BioDelivery Sciences International Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 90.29 8.17 2.55

BioDelivery Sciences International Quarterly Data
Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.17 7.17 5.76 6.31 2.55

Competitive Comparison of BioDelivery Sciences International's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, BioDelivery Sciences International's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioDelivery Sciences International's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioDelivery Sciences International's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where BioDelivery Sciences International's Price-to-Tangible-Book falls into.



BioDelivery Sciences International Price-to-Tangible-Book Calculation

BioDelivery Sciences International's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2021 )
=5.59/1.217
=4.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


BioDelivery Sciences International Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of BioDelivery Sciences International's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


BioDelivery Sciences International (BioDelivery Sciences International) Business Description

Traded in Other Exchanges
N/A
Address
4131 ParkLake Avenue, Suite 225, Raleigh, NC, USA, 27612
BioDelivery Sciences International Inc is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic pain. The company is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA) technology and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of therapies aimed at addressing important unmet medical needs. Its products include Belbuca and Symproic.
Executives
James Vollins officer: See Remarks C/O BIODELIVERY SCIENCES INTERNATIONAL, 4131 PARK LAKE AVE SUITE 225, RALEIGH NC 27607
Mark A Sirgo director C/O BIODELIVERY SCIENCES INTERNATIONAL, 801 CORPORATE CENTER DRIVE -SUITE 210, RALEIGH NC 27607
Broadfin Healthcare Master Fund Ltd director C/O 20 GENESIS CLOSE, ANSBACHER HOUSE, 2ND FLOOR, PO BOX 1344, GRAND CAYMAN E9 KY1-1108
Kevin Kotler director C/O BROADFIN CAPITAL, LLC, 300 PARK AVENUE, 25TH FLOOR, NEW YORK NY 10022
Mary Theresa Coelho officer: See Remarks 52 SUNRISE PARK ROAD, NEW HAMPTON NY 43017
Jeffrey Allen Bailey director, officer: Chief Executive Officer BIODELIVERY SCIENCES INTERNATIONAL, INC., 4131 PARKLAKE AVE., SUITE 225, RALEIGH NC 27612
Todd C Davis director 11119 NORTH TORREY PINES ROAD, SUITE 200, LA JOLLA CA 92037
W. Mark Watson director 324 S. HYDE PARK AVENUE, STE 350, TAMPA FL 33606
Peter Greenleaf director ONE MEDIMMUNE WAY, GAITHERSBURG MD 20878
Broadfin Capital, Llc director 300 PARK AVENUE, 25TH FLOOR, NEW YORK NY 10022
Vanila Singh director C/O BIODELIVERY SCIENCES INTERNATIONAL, 4131 PARKLAKE AVE., SUITE 225, RALEIGH NC 27612
Scott M. Plesha officer: See Remarks 1410 SMYTHE ST DANIEL ISLAND SC 29492
Odonnell Francis E Jr director BIODELIVERY SCIENCES INTERNATIONAL, INC, 4131 PARKLAKE AVENUE, SUITE #225, RALEIGH NC 27612
Herm Cukier director, officer: Chief Executive Officer C/O BIODELIVERY SCIENTES INT., INC. 4131 PARKLAKE AVE, SUITE 225 RALEIGH NC 27612
Thomas B Smith officer: Chief Medical Officer BIODELIVERY SCIENCES INTERNATIONAL, INC., 4131 PARKLAKE AVE SUITE 225, RALEIGH NC 27612

BioDelivery Sciences International (BioDelivery Sciences International) Headlines

From GuruFocus

BioDelivery Sciences International to Host ELYXYB� Investor Day

By Marketwired Marketwired 09-30-2021

Collegium to Acquire BioDelivery Sciences in an All-Cash Deal

By GuruFocusNews GuruFocusNews 02-14-2022